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Precision global health for real-time action
Precision global health, augmented with artificial 
intelligence, has the potential to address transnational 
problems (eg, outbreaks of emerging infectious diseases, 
diabetes, addictions, ageing, or mental health) and 
deliver targeted and effective interventions through 
integrated approaches which combine life sciences, 
social sciences, and data sciences with public support. 
More than half the global population are connected 
to the Internet, mainly through mobile phones, and 
several countries in sub-Saharan Africa are leading the 
annual growth of active mobile social users with over 
17% in 2018. Thus, the role of local populations and 
civil society is more important than ever, to identify 
challenges and work together to address some of the 
most pressing global health issues and sustainable 
development.1
Undoubtedly, major public and global health 
achievements have resulted largely from generic public 
health interventions such as the eradication of smallpox 
with large-scale vaccination campaigns, the iodisation of 
salt, improved access to clean water and oral rehydration 
salts, and mass drug administration to control and 
eliminate neglected tropical diseases. However, so-
called one size fits all interventions tend to neglect 
the idiosyncrasies of social-ecological systems and the 
heterogeneity of populations, including underlying 
health determinants.2 In view of growing complexities 
in global health challenges, there is a need for increased 
precision and adoption of more tailored strategies.
We believe that precision global health can transform 
approaches to reduce the burden of infectious diseases 
in low-income and middle-income countries to a 
similar extent that it has been achieved in high-income 
countries.3 For example, Rift Valley fever is a zoonotic 
arbovirus transmitted to humans through direct contact 
with blood or tissue of infected livestock, or through 
mosquitoes.4 In 2006, the response to an outbreak 
in Kenya was facilitated by the early predictions of risk 
of Rift Valley fever, due to heavy rainfall based on 
remotely sensed environmental data.5 Demographic, 
ecological, environmental, and socio-economic 
predictors can help identify Rift Valley fever hotspots and 
target surveillance at the right time and location.6 With 
Rift Valley fever joining WHO’s Blueprint list,7 Kenya 
has been moving towards an integrated surveillance and 
response system, based on cross-sectoral collaboration 
and community participation (eg, cattle herders) 
through digital tools. The Kenyan governmental 
Zoonotic Disease Unit has favoured data sharing across 
sectors and joint prioritisation for targeted control 
of zoonoses.8 In collaboration with mHealth Kenya, 
mobile phone technologies have improved the country’s 
capacity to detect, prevent, and control zoonotic diseases 
such as Rift Valley fever more quickly and precisely. The 
Kenyan approach is promising and could be extended 
and further developed regionally to aim for the control 
of Rift Valley fever in the Horn of Africa (ie, Ethiopia, 
Somalia, Eritrea, and Djibouti).
In 2012, WHO and the International Telecommunication 
Union launched Be he@lthy, be mobile, an international 
initiative working with governments to scale up 
mobile health and access to health services to improve 
prevention, management, and control of non-
communicable diseases and their risk factors. With non-
communicable diseases being the leading cause of 
death globally, the opportunities in precision global 
health must be leveraged and developed in equitable 
ways to improve people’s health and wellbeing in high-
income, middle-income, and low-income countries. 
The government of Rwanda has used drones since 
2016 through the drone company Zipline, to deliver 
blood to 21 district hospitals at a relatively low cost, 
reducing the average blood delivery time from several 
hours to less than 45 minutes. This blood product 
delivery has to date made more than 25 000 life-saving 
deliveries, contributing to a reduction in preventable 
deaths. In April 2019, Zipline launched the world’s 
most extensive drone delivery network in Ghana, with 
a revamped fleet of larger and faster drones. Drones are 
being tested for a number of other health applications, 
including support for tuberculosis control, and delivery 
of snakebite antivenoms or contraceptives. Although in 
its infancy, and curbed by currently restrictive national 
air regulations, the field of deploying drones for medical 
delivery has passed the proof-of-concept stage in 
different settings and appears ready for targeted scale-
up in the precision global health agenda.
Data access and sharing in global health have been 
recurring challenges attributed not only to privacy 
concerns, but also to unaligned incentives, ambiguous 
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data ownership, and attribution of credit. Adhering 
to principles of research partnership,9 innovative 
data governance models, and oversight mechanisms 
that promote accountability can help overcome such 
challenges and prevent the exploitation of privacy 
or data ownership claims that obstruct legitimate 
and ethically justified data access for global health 
purposes. Such governance models are rooted in 
partnership principles and data fairness, with the latter 
prescribing the utilisation of data for the promotion of 
public good.
To achieve precision in the detection, prevention, 
control, and surveillance of diseases, countries need 
data intelligence: the capacity to pick up and understand 
data signals from multiple interoperable sources for 
near real-time analysis. Such data intelligence should be 
converted into usable tools that prevent and control the 
effects of diseases and disease outbreaks.10
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